Lopinavir/Ritonavir (Kaletra, Aluvia)

Published January 25, 2001; Updated June 2018
Susa Coffey, MD
Selected Reference
6. Becker S, Brun S, Bertz R, et al. ABT-378/ritonavir (ABT-378/r) and Efavirenz: 24 Week Safety/Efficacy Evaluation in Multiple PI Experienced Patients. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 2000; Toronto. Abstract 697.